Hemophilia
Keywords:
-Abstract
-
Downloads
References
อำไพวรรณ จวนสัมฤทธิ์. โรคฮีโมฟีเลีย. ใน พงษ์จันทร์ หัตถึรัตน์, อำไพวรรณ จวนสัมฤทธิ์, ภัทรพรพร อิศรางกูร ณ อยุธยา, บรรณาธิการ. โลหิตวิทยาในเด็ก. พิมพ์ครั้งที่ 3. กรุงเทพฯ : ชัยเจริญ, 2538:206-42.
Hilgartner MW, Corrigan Jr JJ. Classic hemophilia. In: Miller DR, Baehner RL, eds. Blood Diseases of Infancy and Childhood. 7th ed. St. Louis : Mosby, 1993-44.
Nilsson IM. Haemophilia. Stockholm: Pharmacia, 1994:2-5.
Ingram GIC. The history of haemophilia. Haemophilia 1997;3:5-15.
WHO Bullentin 1991;69:1-148.
Schulman I, Smith CH. Hemorrhagic disease in an infant due to deficiency of a previously undescribed clotting factor. Blood 1952;7:794-807.
Biggs R, Douglas AS, Mactarlane RG, et al. Christmas disease: a condition previously mistaken for hemophilia. Br Med J 1952;2:1378-82.
Montgomery RR, Gill JC, Scott JP. Hemophilia A and hemophila B. In : Nathan DG, Orkin SH, eds. Nathan and Oski's Hematology of Infancy and Childhood. 5th ed. Philadelphia : W.B. Saunders, 1998,1632-44.
Furie B, Furie BC. Molecular basis of hemophilia. Semin Haematol 1990;27:270-85.
Gitschier J, Kogan S, Diamond C, Levinson B. Genetic basis of hemophilia A. Thromb Haemost 1991;66:37-9.
O' Brien D. The purification of factor VII and the characterization of the human factor VIII gene. Hemophilia 1995;1:3.
Peake I. The molecular basis of haemophilia A. Hemophilia 1998;4:346-9.
Antonarakis SE. Molecular genetics of coagulation factor VIII gene and haemophilia A. Haemophilia 1998;4:1-11.
Lillicrap D. The molecular basis of haemophilia B. Haemophilia 1998;4:350-7.
Pungamritt P, Treesucon A, Petrarat S, et al. Factor VII gene deletion in a Thai hemophilia A patient. Wil be pubished in Asia Pacific J Molecular Biology & Biotechnology 1998;2:6.
Thonglairoam V, Yenchitsomanus P, Pung-amritt P, et al. Study of factor VIII gene inversion in Thai hemophilia A patients. Presented at the 10th Seminar in Genetic Diseases in Thailand 1997; Mar 19-21.
Yenchitsomanus P. Development of method for detection of mutations in factor VIII gene by mRNA analysis. October, 1998 (Personal communication).
Bloom AL. Progress in the clinical management of haemophilia. Thromb Haemost 1991,66:166-77.
Lusher JM. Considerations for current and future management of hemophilia and its complications. Hemophilia 1995;1:2-10.
Chuansumrit A. Meeting the needs of haemophilic children in developing countries. Haemophilia 1998;4:19-23.
Seremetis SV. Modern treatment of haemophilia : choice of products for the treatment of haemophilia A and B. Haemophilia 1995;1:21-5.
Hoots K, Canty D. Clotting factor concentrates and immune function in haemophilic patients. Hemophila 1998;4:704-13.
Kaufman RJ, Pipe SW. Can we improve on nature? "Super molecules" of factor VIII. Haemophilia 1998;4:370-9.
Recombinant factor VIII. In : Miescher PA, Jatte ER, eds. Seminars in Hematology. Philadelphia : WB Saunders, 1991;28:1-56.
Martinowitz U, Schulman S. Fibrin sealant in surgery of patients with hemorrhagic diathesis. Thromb Haemost 1995;74:486-92.
Martinowitz U, Spotnitz WD. Fibrin tissue adhesives. Thromb Haemost 1997;76:661-6.
Suwanuraks M, Chuansumit A, Sriudompompom N. The use of fibrin glue as an operating sealant in dental extraction of bleeding disorder patients. Haemophilia 1996;2:47.
Peake I. The role of gene therapy in hemophilia. Haemophilia 1995;1:40-3.
Connelly S, Kaleko M. Haemophilia A gene therapy. Haemophilia 1998;4:380-8.
Kay MA. Hepatic gene therapy for hemophilia B. Haemophilia 1998;4:389-92.
Fields PA, Pasi KJ. Gene therapy for haemophilia : how far have we come? Haemophilia 1998;4:699-703.
Ehrenforth S, Kreutz W, Scharrer I, et al. Incidence of development of factor VIII and IX inhibitors in haemophiliacs. Lancet 1992;339:594-8.
Addiego J, Kasper CK, Abildgard C, et al. Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII. Lancet 1993;342:462-4.
Tuddenham EGD, Mcvey JH. The genetic basis of inhibitor development in hemophilia A. Haemophilia 1998;4:543-5.
Hay CRM. Factor VIII inhibitors in mild and moderate severity haemophilia A. Haemophilia 1998;4:558-63.
Brettler DB. Inhibitors of factor VIII and IX. Haemophilia 1995;1:35-9.
Kreuz W, Ehrenforth S, Funk M, et al. Immune tolerance therapy in pediatric hemophiliacs with factor VIII inhibitors: 14 years follow-up. Haemophilia 1995;1:24-32.
Mahasandana C, Tanphaichitr VS, Suvatte V, et al. Treatment of severe bleeding in hemophilia A with factor VIII inhibitor. J Med Assoc Thai 1988;71:154-8.
Chauansumrit A, Krutvecho T, Isarangkura P, et al. Exchange transfusion and pulse steroid therapy in a hemophiliac with inhibitor. J Med Assoc Thai 1989;72:139-43.
Goodeve AC. Advances in carrier detection in hemophilia. Haemophilia 1998;4:358-64.
Mahasandana C, Veerakul G, Yenchitsomanus P, et al. DNA linkage analysis studies in 52 Thai hemophilia A families. Presented at the Siriraj Scientic Congress.4-8 Mar 1996.
Winship PR, Nichols CE, Chuansumrit A, Peake IR. An Mse I RFLP in the 5 flanking region of the factor IX gene : its use for haemophilia B carrier detection in Caucasian and Thai populations. Br J Haematol 1993;84:101-5.
Goodeve AC, Chuansumrit A, Sasanakul W, et al. A comparison of the allelic frequencies of ten DNA polymorphisms associated with factor VIII and factor IX genes in Thai and Western European populations. Blood Coagul Fibrinolysis 1994;5:29-35.
Chuansumrit A, Goodeve A, Sasanakul W, et al. DNA polymorphisms for carrier detection of hemophilia in Thailand. Southeast Asian J Trop Med Pub Hlth 1995;26:201-6.
Chuansumrit A, Sugkraroek P, Sasanakul W, et al. Prevention of hemophilia by sex selection. Thai J Hematol Transf Med 1996;6:39-42.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
